chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Absence seizure- twitching lasting about 20 minutes, episodes continued for 2 months decreasing in frequency.  No previous history of seizures.
Information has been received from a physician concerning a female who in February 2008, was vaccinated with the first dose of GARDASIL (lot# 660387/1967U). Per the reporter, the patient developed hives within an hour and a half of vaccination. No other symptoms were involved. The patient sought unspecified medical attention in the physician's office. Topical BENADRYL was used and the symptoms resolved the same day. No further information is available. Additional information has been requested. This is in follow-up to reportz(s) previously submitted on 5/14/2008.  No other symptoms were involved.  The patient thought unspecified medical attention in the physician's office.  BENADRYL was used and the symptoms resolved the same day.  No further information is available.  Additional information received from a Form (21-MAY-2008). The patient had no episodes of hives in the previous week other than 8 day prior while on a camping trip.  Additional information is not expected.
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (lot# not reported). On an unknown date while on ZOSTAVAX, the unspecified patient developed shingles. The outcome of the event was unknown. The relatedness for the event with the therapy was not provided. Additional information is not expected.
Pt was recovering from presumed Post-COVID syndrome and had exacerbation of all her symptoms:  fatigue, insomnia, body vibration, headaches, body and jaw tingling, swollen lymph nodes
This spontaneous report was received from a physician via a company representative regarding to a female patient of an unknown age. The patient's concurrent conditions and medical history were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (lot #, dose and route were not reported). On an unknown date in June 2015 (reported as last week), the patient was diagnosed with shingles. The patient was referred to an unknown physician for treatment. The outcome of shingles was unknown.  The reporter did not provide the relatedness of shingles with ZOSTAVAX. Additional information has been requested.
Infection of the skin/arm. Patient received cephalexin and is in good spirits as of a few hours after picking up and starting the cephalexin.
Pt was rear facing in her car seat. Mother noticed," facial twitching on the right side with her mouth drawing towards her ear, along with eye twitching and her eyes were rolling, and her face flopped the other way." She would not respond to her name, mom did not notice her extremities. She returned to our office and was found to be slightly tired, but otherwise normal acting. Referred to make apt with neurology.
The night of the vaccination (in which I had both the covid modern booster and the flu shot in the same arm) I began to get complete whole body joint pain and muscle aches.  That lasted for about 24 hours. Then the third day my left arm was swollen at the injection site and itchy. Also my lymph node under my left arm was hurting. Now today the fourth day my lymph node isn't hurting as much but my arm is still a little bit swollen and itchy but not as bad as yesterday.
Patient has a seizure we took him to the ER they said he was fine, the next day he had another seizure took him to the ER said he was fine but afterwords could not hold up his head and was at a newborn state. Currently he has for specialist with kids on the move, he was not able to do anything including roll over Until he was 18 months old.
Information has been received from a nurse refers to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of 0.5 ml VAQTA (lot # K005802, 24-OCT-2015), intramuscular which were exposed to 32.5F for 2 hours. This event was considered as incorrect product storage. No adverse effects reported. This is one of several reports received from same source. Additional information has been requested.
No additional AE reported; HCP called to report T/E for VARIVAX. VARIVAX outcome was Supported. HCP stated it was administered to a patient. No additional AE reported. No PQC reported.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported.      On 29-SEP-2023, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number X006983, expiration date 07-MAR-2025 (dose and route of administration not reported) for prophylaxis (product storage error). No adverse event was reported.
The symptoms I experience started about 6-7 hours following the vaccine. My symptoms consisted of body aches in my upper and lower back and throughout my upper arms. These symptoms dissipated 24 hours following the vaccine injection. At 36 hours following the vaccine my symptoms subsided completely.
Red circular Rash, Raised, itchy, warm to touch treatment: tylonal, ice, hydrocortisone Cream, Benadryl for the itch.
CERVARIX was given the male patient, while it should be given to the female patients, only.
Severe headache 3 hours after injection. Also there is numbness on the bottom only of both feet. I still have the headache 3 days later with nausea at times because of the pain. Feet are also still numb. There was some body aches too that was only on the entire left side of my body.
No adverse effect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Modera. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use.
Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2021: Follow up received contains no new information.
Arm painful (L) deltoid, injection site reaction redness. Arm red, tender/sore, painful. Recommended if very painful that one can't stand to see Urgent care/ER. Normal side effects Pt. says next day it's when she felt soreness.
Bilateral joint pain and inflammation in hands and wrists and knees, resulting in probable diagnosis of an autoimmune disease, rheumatoid arthritis.  Current treatment is NSAIDs for pain and inflammation. Pending prescription for Prednisone and Meloxicam. Referral made 12/10/2021 to rheumatologist.
NSTEMI, ED visit to hospital admit. This visit is within 6 weeks of receiving vaccine.
fever; tiredness; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (fever) and FATIGUE (tiredness) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    The patient's past medical history included COVID-19 in July 2020.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 75 mg once. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PYREXIA (fever) and FATIGUE (tiredness). At the time of the report, PYREXIA (fever) and FATIGUE (tiredness) outcome was unknown. 2nd dose AE      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported.
Numbness in left facial cheek that spread to chin, right facial cheek, lips, and nasal septum.
1NOV95 big blotch +- 3in below inj site;it's fiery red +- 20 red, puffy, hive-like blotches @ inj site;lower one is kind of puffy & not real hard;no fever, malaise
REDNESS AND SWELLING AROUND INJECTION SITE. ARM PAIN. FEVER AND BODY ACHES LASTING 48HRS +.
Two days after my 1st Pfizer COVID vaccine, I found myself having an allergic reaction to nuts. Since March of 2021 I have continued to have allergic reactions to all nuts. These reactions include an itchy tongue and a rash around my mouth. My hands will occasionally be itchy as well. This typically will last for a few hours and then go away. I have not experienced any difficulty breathing at all during these reactions. There is no family history of nut allergies, and for 34 years of my life I had not had any adverse reactions to any nuts that I regularly consumed. Of course I cannot determine if this is correlation or causation, but wanted to make this report in case others are also finding themselves with food allergies following either dose of their COVID vaccine.
reactions consistent with grade 3 reactions/pain in the arm where the injection was given; reactions consistent with grade 3 reactions/ feeling flu-like symptoms; This case was reported by a nurse via sales rep and described the occurrence of pain in arm in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and influenza-like symptoms. On an unknown date, the outcome of the pain in arm and influenza-like symptoms were recovered/resolved.   It was unknown if the reporter considered the pain in arm and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable. The nurse reported that after Shingrix vaccination the patient experienced pain in arm where the injection was given, along with feeling flu-like symptoms for two to three days. Reactions were consistent with grade 3. No further information was provided. The reporter did not consent to follow up.
Patient felt unconscious for 5 seconds and slide off his chair at observation area after vaccination. No allergic reaction noticed to injection site. Gained consciousness soon and was alert and oriented  x 4. no visible trauma, v/s stable during the triage period. Patient stated that he did not eat breakfast and not well hydrated, is taking anti anxiety medication on regular basis. Patient has history of passing out during blood draw (acc to him). A bottle of water and juice given to drink.  Pt had mild redness at right elbow after fall, no swelling noticed, icepack applied, no pain, no skin tear.  Patient felt better and walks comfortably through the hall to parking lot after 25 min of incident.
I'm afraid I'm going to die; Recurrent fever/Low grade fevers; Malignant fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTHERMIA MALIGNANT (Malignant fever) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A, 041L20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke.   On 12-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced HYPERTHERMIA MALIGNANT (Malignant fever) (seriousness criterion medically significant) and PYREXIA (Recurrent fever/Low grade fevers). On an unknown date, the patient experienced FEAR OF DEATH (I'm afraid I'm going to die). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Fever, at an unspecified dose and frequency. At the time of the report, HYPERTHERMIA MALIGNANT (Malignant fever) and FEAR OF DEATH (I'm afraid I'm going to die) outcome was unknown and PYREXIA (Recurrent fever/Low grade fevers) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 (High) fevers have been up to 99F and 100F..         No relevant concomitant medications were reported. Patient reported that the fever is getting worse.  This case concerns a  61-year-old, male patient with no relevant medical history, who experienced the unexpected events of Hyperthermia malignant, Fear of death and the expected event of Pyrexia. The events occurred on an unknown date after the third dose of mRNA-1273 Vaccine and remains unresolved. The rechallenge was unknown since no information about the events of the previous dose was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2021-387680 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2021: Follow up received contains Significant Information. Case is upgraded from Non serious to serious Medically significant. Events Hyperthermia malignant and Fear of death are added.; Sender's Comments: This case concerns a  61-year-old, male patient with no relevant medical history, who experienced the unexpected events of Hyperthermia malignant, Fear of death and the expected event of Pyrexia. The events occurred on an unknown date after the third dose of mRNA-1273 Vaccine and remains unresolved. The rechallenge was unknown since no information about the events of the previous dose was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
shortness of breath with a tingly throat. Left sided facial and arm pain. reported to ER- Diphenhydramine 25mg given PO. patient reported feeling less tingling in her throat. Diphenhydramine dispensed by PA to take home.
Diabetic ketosis; COVID-19 virus infection; Hyponatremia; ESRD (end stage renal disease) on dialysis; Generalized weakness
pt recvd vax & devel a fever of 103-105 10 days p/vax; No further details were provided; MD reported 15 similar pt's;
3-4 days after shot - pt noticed a pimple-like mark over area - then the are expanded to a circular, quarter-sized red-raw area that had tiny blisters on it.  Pt has seen 4 doctors and the 5th is scheduled for today - out of 5 MDs - 2 are specialists.
I tested positive for COVID-19 on 7/10/22. I had a stuffy nose, congestion, body aches, headache, and cough with phlegm. We were planning on keeping my grandkids so I decided to take a COVID-19 test and I ended up testing positive. I contacted my doctor and he prescribed Molnupiravir. My symptoms are getting much better now.
Allergic type reaction. Had injection of Prevnar 20 in left arm and Shingrix in right arm. No reaction with shingles vaccine in right arm. Left arm severely swollen and very hot to touch. Could not raise arm and swollen and sore in armpit area. The pharmacy recommended to see Doctor to see if antibiotics needed. She visited an ER. The Doctor suspects allergic reaction, but is giving her cephalexin 500mg  every 6 hours for 5 days just in case.  We are following up with patient from the pharmacy in the next couple of days to review her status.
Date the vial was initially stored in the refrigerator on 2JUNE2022, Date of administration of vaccine on 2AUG2022; No adverse event; Patient received Moderna Covid-19 vaccine past the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine past the 30 day beyond use date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 2JUNE2022, Date of administration of vaccine on 2AUG2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A22A, 041L20A and 029L20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Aug-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Aug-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine past the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 2JUNE2022, Date of administration of vaccine on 2AUG2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine past the 30 day beyond use date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 2JUNE2022, Date of administration of vaccine on 2AUG2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine past the 30 day beyond use date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 2JUNE2022, Date of administration of vaccine on 2AUG2022).    No concomitant medications were provided. The vial did not undergo any temperature excursions. Patient did not experienced any adverse reactions with first, second and first booster vaccinations. No treatment medications were reported.   This case was linked to MOD-2022-629212 (Patient Link).
Broke out with rash the evening vaccine was given. Had welts that lasted a very short time. No treatment.
This medically confirmed spontaneous report (initial receipt: 27-Sep-2012) concerns a 58-year-old female patient, who was allergic to latex. On 25-Sep-2012 the patient received AFLURIA (batch number: P59207) injection at a dose of 0.5 mL once intramuscularly. On 26-Sep-2012, after receiving a dose of AFLURIA, the patient's skin turned light pinkish color about the size of a baseball at the injection site. The patient sought medical attention by calling the pharmacist. Treatment included diphenhydramine cream and tablets. The event outcome was not recovered.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. During 2015, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 30-MAR-2016, the patient was treated at a medical office for a blistering vesicular outbreak and decreased immune symptoms which was then diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
1st: subjective sense of SOB: not feeling like I could get a full breath with mask on (O2 sat at 96%). Followed by fever during the hours of 0900-2000 of >101 degrees F. Managed with ASA the fever came back the night of the 28th into morning of 29th of 99 degrees F. SOB sense including tachypnea of 22-26 during the day of the 29th. Fever has not returned on 30 January, only minimal symptoms of SOB, no tachypnea. HR & BP not measured. Patient (self an RN) self-treated with NSAIDS, ie: ASA. Other noteworthy: subject (me) received 2 doses of the Astra Zeneca in study in Dec 2020 & Jan 2019 - confirmed as subject was "unblinded" when offered Covid vaccination by workplace.
Throat felt funny, chest felt warm, pulse increased. Antihistamine taken. Vitals monitored - O2, BP, HR for 30 min. Returned to work with a friend after.
pt exp severe screaming, diarrhea, bloody stool, not eating, vomiting; not sleeping, fever, uncomfortable, squirming; no wet diapers at times; 4-6 hr no diarrhea then constant diarrhea; would go into trance like state
Pt vaccinated with DTP developed fever to 102, x 3days, fontanelle bulging, child otherwise playful, eating, not lethargic, child not hospitalized. Within 24 hrs, fever & Fontanelle returned to normal.
like the ones previous I suffered from the typical arm soreness, fatigue and inflammation of lymph nodes; like the ones previous I suffered from the typical arm soreness, fatigue and inflammation of lymph nodes; like the ones previous I suffered from the typical arm soreness, fatigue and inflammation of lymph nodes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Dec2020 at 07:30 as dose 1, single (Lot number: ER5730), in left arm and on 20Jan2021 at 08:00 as dose 2, single (Lot number: EL8982), in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Leg weakness and shakiness", start date: 2021 (ongoing); "Drop in blood sugars", start date: 2021 (ongoing); "PSA" (unspecified if ongoing); "Low Thyroid" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "Weekend immnune system" (unspecified if ongoing). Concomitant medication(s) included: RASUVO intramuscular taken for prostatic specific antigen (ongoing); COSENTYX intramuscular taken for prostatic specific antigen (ongoing); LEVOTHYROXINE oral taken for hypothyroidism (ongoing); CRESTOR oral taken for blood cholesterol increased (ongoing). The following information was reported: LYMPHADENITIS (non-serious), PAIN IN EXTREMITY (non-serious), FATIGUE (non-serious), outcome "recovered" and all described as "like the ones previous I suffered from the typical arm soreness, fatigue and inflammation of lymph nodes".  Additional Information: Patient received my Booster shot 22Oct2021. And like the ones previous she suffered from the typical arm soreness, fatigue and inflammation of lymph nodes along side which took about 7 days to go away.  Follow-up attempts are completed. No further information is expected.
Extremely sore upper arm, headaches, sore stomach, dizziness & nausea, no appetite, lethargic (completely lost a day of my life as I felt miserable & unable to function--tired & very weak). Had similar symptoms with first in series given on Sept. 5, 2018 but not this debilitating.
The patient received Tdap and experienced chills, diarrhea and vomiting 1-2 hours after injection. The symptoms subsided in 2 to 3 days.
Pretty sudden,  difficulty with respirations, any walking getting very winded, extreme weakness in lower ext x 1 week. Off balance, having to use arms to lift legs, funny feeling in toes, not able to lift legs.
Fever, as high as 102.9, heart rate 120-140, chills, body aches, hives, sore throat, headache, sore arms (both).